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This study was to investigate the effect of macelignan on Porphyromonas gingivalis supernatant-induced uPA
expression via regulating mitogen-activated protein kinase (MAPK) and activating protein-1 (AP-1) signaling
pathways in human oral epithelial KB cells using casein zymography, Western blotting, reverse transcription-
PCR and reporter gene assays. Zymographic analysis of secreted enzymes identified the main caseinolytic band
at 54 kDa. Macelignan inhibited the expression of uPA protein and mRNA, as well uPA secretion, in KB cells
exposed to P. gingivalis supernatant. Consistent with these findings, macelignan suppressed phosphorylation of
p38 and c-Jun N terminal kinase (JNK) in P. gingivalis supernatant-induced KB cells. The levels of c-Fos and
phosphorylated c-Jun, which together form AP-1, the transcription factor that is involved in uPA gene expression,
were partially reduced by macelignan. Macelignan also blocked P. gingivalis supernatant-induced AP-1 activity in
these cells. These results suggest that macelignan decreased P. gingivalis supernatant-induced uPA expression
by blocking AP-1 activity, which may be mediated by inhibition of phosphorylation of p38 and JNK in KB cells.
Macelignan may potently use for the modulation of periodontal inflammation.
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INTRODUCTION
Nutmeg (Myristica fragrans Houtt.), a perennial herb
native to Indonesia and to the Molucca islands, in
particular, has traditionally been used for culinary and
medicinal purposes (Janssens et al. 1990; Olajide et al.
1999; Sonavane et al. 2002; Narasimhan & Dhake 2006;
Cho et al. 2007). Macelignan is a bioactive compound
with molecular weight of 328 present in nutmeg and has
been reported to possess antioxidant, anti-inflammatory,
anti-diabetic, hepatoprotective and skin-whitening
properties (Jin et al. 2005; Cho et al. 2008; Han et al. 2008;
Sohn et al. 2008). Our previous studies demonstrated that
macelignan possesses anticariogenic and anti-biofilm
activities that are effective against oral pathogens such
as Streptococcus mutans, S. sanguinis, and Actinomyces
viscosus (Chung et al. 2006; Yanti et al. 2008), suggesting
potential application of macelignan in treatment of dental
plaque. During progression of periodontal disease, plaque
accumulation in response to bacterial products triggers
the host cells to release inflammatory mediators and leads
to the breakdown of extracellular matrix. The process of
connective tissue breakdown is facilitated by the action
of serine proteinases, such as matrix metalloproteinases
(MMPs) and plasminogen activators (PAs).
The plasminogen/plasmin system plays a central role
in extracellular proteolysis by facilitating connective tissue
breakdown, which leads to inflammation. Two PAs, i.e.
urokinase-type plasminogen activator (uPA) and tissue-
type plasminogen activator (tPA), convert plasminogen
into plasmin; plasmin is another serine protease that
degrades fibrin and activates MMPs (Andreasen et al.
1997). uPA is a 54 kDa serine protease and is highly
expressed in inflamed and healing cells in response to
cytokines and bacterial products. Several studies have
demonstrated that regulation of uPA expression in gingival
fibroblasts is tightly controlled by the growth factors
epidermal growth factor (EGF) and transforming growth
factor (TGF)-â1, the cytokine interleukin-1â and the
bacterial product Porphyromonas gingivalis
lipopolysaccharide (LPS) (Ogura et al. 1999, 2001; Smith
et al. 2004; Smith & Martinez 2006).
Identification of a potent natural inhibitor of uPA has
been the subject of a great deal of research interest because
of the potential benefits for periodontal therapy. To date,
only a few bioactive compounds that exhibit an inhibitory
effect on uPA expression and low toxicity to normal cells
have been identified. Genistein and curcumin suppress
EGF-induced uPA expression in human gingival fibroblasts
(Smith et al. 2004), strongly suggesting that these
compounds will be useful in the control of periodontal
inflammation. Also, epigallocatechin-3-gallate (EGCG) from
green tea has been shown to have an effect on uPA
expression in human oral cancers and fibrosarcomas (Kim
et al. 2004; Ho et al. 2007), suggesting that EGCG may be
a potent cancer chemopreventive agent. The goal of the
present study was to examine the inhibitory effect of
macelignan isolated from M. fragrans Houtt. on uPA
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expression in human oral epithelial KB cells exposed to
P. gingivalis supernatant in vitro. The molecular
mechanism by which macelignan modulates the relevant
signaling molecules, i.e., mitogen-activated protein kinase
(MAPK) pathway and activating protein-1 (AP-1),
involved in uPA expression in P. gingivalis supernatant-
induced KB cells was also investigated.
MATERIALS  AND  METHODS
Isolation of Macelignan. The dried seed kernels of
M. fragrans Houtt. (Myristicaceae) were collected in
Jakarta, Indonesia, and identified at Department of Oriental
Medicinal Materials and Processing, Kyunghee
University (Yongin, Korea). A voucher specimen (H010)
is deposited in the Department of Biotechnology, Yonsei
University (Seoul, Korea). The dried seed kernel of M.
fragrans Houtt. (100 g) was extracted with 100% ethanol
(400 ml), and the extract (7 g) was further fractionated with
ethyl acetate. The ethyl acetate fraction (4.2 g) was applied
to a silica gel column (60, 70-230 mesh, Merck) and eluted
with n-hexane and ethyl acetate solution (10:1, v/v) to
give six fractions (FI to FVI). FIII was further separated
with n-hexane and ethyl acetate solution (20:1, v/v),
yielding FIII-B (0.52 g). FIII-B was eluted with 80%
methanol using Rp-18 column chromatography
(LiChropep, 25-40 ìm, Merck), yielding compound III-B-2
(0.5 g). Comparison of several spectral data of compound
III-B-2 including 13C-NMR, 1H-NMR, 13C-DEPT, 1H-1H
COSY, 1H-13C HSQC, 1H-13C HMBC, and FAB-MS with that
in the literature (Woo et al. 1987) suggested the chemical
structure to be macelignan 99% (Figure 1) or (8R,8S)-7-
(3 ,4-methylenedioxyphenyl ) -7- (4-hydroxy-3-
methoxyphenyl)-8,8-dimethylbutane.
Instrumentation. NMR spectra were recorded on a
Bruker Avance-500 spectrometer at 600 MHz for 1H- and
13C-NMR in CDCl3 with TMS as an internal standard.
Complete proton and carbon assignments were based on
1D (1H-, 13C-, 13C-DEPT) and 2D (1H-1H COSY, 1H-13C
HSQC, 1H-13C HMBC) NMR experiments. Mass spectra
(FAB-MS) were measured using a JMS-700. All
instrumental spectra are available upon request.
Cell Culture and Cell Viability. KB cells were cultured
in a 5% CO2 atmosphere at 37 oC in Dulbecco’s Modified
Eagle’s Medium (DMEM; Gibco) supplemented with
100 U/ml of penicillin A, 100 U/ml of streptomycin and
10% heat-inactivated fetal bovine serum (FBS). The cells
were seeded at a concentration of 2 x 105 cells/ml
per 75 cm2 flask and cultured for 24 hours. Confluent cells
were detached by trypsinizing for 2 minutes and aliquots
of separated cells were subcultured. The effects of
P. gingivalis supernatant and macelignan on cell viability
were evaluated with an MTT (3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide; Sigma-Aldrich)
colorimetric assay according to the method of Mosmann
(1983).
Bacterial Supernatant and Sample Treatment. P.
gingivalis supernatant was prepared as described by
Chang et al. (2004) with a slight modification. Cells were
seeded at a concentration of 2 × 105 cells/ml in 6-well
plates and cultured for 24 hours in DMEM-FBS. After
washing twice with Dulbecco’s phosphate-buffered saline
(DPBS), the cells were incubated in serum free-DMEM
without P. gingivalis supernatant (negative control group),
with 10% P. gingivalis supernatant (positive control group)
or with 10% P. gingivalis supernatant plus various
concentrations of macelignan or MAPK inhibitors (U0126,
SB203580, and SP600125) or uPA inhibitor (amiloride) or
MMP inhibitor (GM6001). The cellular lysates were also
collected for this experiment.
Casein Zymography. Secretion of uPA in the
conditioned medium was measured by casein zymography
(Bodet et al. 2007). Briefly, the conditioned media from the
negative control, positive control, and treatment group
(macelignan) were collected and subjected to
electrophoresis with 10% SDS polyacrylamide gels
containing 0.5% skim milk and human plasminogen 2 mg/ml.
uPA was detected at 54 kDa as clear zones against the
dark background. Effects of MAPK inhibitors (U0126,
SB203580, and SP600125), uPA inhibitor (amiloride) and
MMP inhibitor (GM6001) on uPA secretion in the
conditioned media were also determined by casein
zymography.
Reverse Transcription-PCR. uPA mRNA in the cellular
lysates was determined by RT-PCR. Total RNAs from
cellular lysates of negative control, positive control and
treatment group (macelignan) were extracted as previously
described (Yanti et al. 2009). The human oligonucleotide
primers for uPA and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) were designed according to a
PCR primer selection program at the website of the Virtual
Genomic Center from the GenBank database. uPA primers
were designed as 5’CTGCCTGCCCTGGAACTCTG3’ for
forward and 5’CCTTGCGTGTTGGAGTTAAG3’ for
reserve. GAPDH primers were 5’ATTGTTGCCATCAATG
ACCC3’ for forward and 5’AGTAGAGGCAGGGATGAT3’
for reverse. PCR consisted of 35 amplification cycles
and each cycle was carried out for 30 seconds at 94 oC,
30 seconds at annealing temperature (56 oC for uPA and
48 oC for GAPDH) and 1 minute at 72 oC in a thermal cycler
(Gene Amp PCR System 2700). The human GAPDH
MeO
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Figure 1. Structure of macelignan.
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housekeeping gene was used as an internal control to
standardize the relative expression levels for uPA. PCR
products were separated electrophoretically in a 2%
agarose DNA gel and stained with ethidium bromide.
Western Blotting. To determine uPA protein
expression, the conditioned media from the negative
control, positive control, and treatment group (macelignan)
were concentrated with Fast-Con Protein Concentration
kit and subjected to Western blotting. To determine the
expression of MAPK phosphorylation, c-Jun
phosphorylation and c-Fos expression, cellular lysates
from the negative control, positive control and treatment
group (macelignan) were prepared and assayed by
Western blot analysis. Proteins (50 µg) were resolved by
10% SDS-PAGE and transferred to nitrocellulose transfer
membranes. The membranes were blocked with 5% skim
milk for 1 hour at room temperature and then probed with
the following primary antibodies: anti-rabbit polyclonal
uPA, anti-mouse monoclonal p-ERK1/2, anti-mouse
monoclonal p-p38, anti-mouse monoclonal p-JNK, anti-
mouse monoclonal c-Jun or anti-rabbit polyclonal c-Fos
at a 1:1000 dilution overnight at 4 oC. After three washes,
the blots were subsequently incubated with the secondary
antibody peroxidase-conjugated anti-mouse IgG or anti-
rabbit IgG at a 1:4000 dilution for 2 hours at room
temperature. The blots were stained with SuperSignal
West Femto Maximum sensitivity substrate (Thermo
Scientific) and visualized using a LAS 3000 Bio Imaging
Analysis System. Equal loading of blots was
demonstrated by stripping blots and reprobing with
antibodies for anti-rabbit polyclonal ERK1/2, anti-rabbit
polyclonal p38, anti-rabbit polyclonal JNK, anti-rabbit
polyclonal c-Jun or anti-mouse monoclonal α-tubulin.
Reporter Gene Assay. Cells were seeded at a
concentration of 1 × 106 cells/ml in 6-well plates and
cultured in DMEM-FBS for 6 hours at 37 oC in a 5% CO2
atmosphere prior to the experiments. For transient
transfection, a 2.0 µg AP-1 luciferase reporter plasmid was
mixed with Lipofectamine reagent in 100 µl of serum-free
DMEM. A 0.25 µg of â-galactosidase plasmid was used as
the internal control. Cells were incubated for 5 hours. For
luciferase assays, cells were washed twice with DPBS after
5 hours of transfection, and treated with various doses of
macelignan (5, 10, and 25 µM), amiloride (25 µM), and
GM6001 (25 µM) for 48 hours. Cell lysates were collected
and luciferase activity was tested using a luciferase assay
system according to the manufacturer’s instructions.
Firefly luciferase activities were standarized for â-
galactosidase activity.
Statistical Analysis. Triplicate experiments were
performed throughout this study. All data are presented
as the mean + standard deviation (SD). The significance
of differences between control and treated groups were
statistically analyzed by the paired Student’s t-test.
RESULTS
Cytotoxicity in KB Cells Treated with P. gingivalis
Supernatant and Macelignan. KB cells were found to
produce primarily uPA and secretion of uPA was
upregulated by exposure to P. gingivalis supernatant for
48 hours in culture. At a concentration of 10%, P.
gingivalis supernatant optimally increased the level of
uPA expression compared to expression in unstimulated
cells (Figure 2a) but had no effect on cell viability.
Macelignan treatment up to a concentration of 25 ìM had
no effect on the viability of either untreated or P.
gingivalis supernatant-treated KB cells, suggesting that
the inhibitory effect of macelignan on uPA expression was
not attributable to cytotoxicity (Figure 2b).
Macelignan Inhibited the Expression of uPA Secretion,
Protein, and mRNA Induced by P. gingivalis Supernatant.
The primary band detected by casein zymography in
conditioned medium of untreated and P. gingivalis
supernatant-treated KB cell cultures had a molecular
weight of 54 kDa and was identified as uPA (Figure 3).
Addition of 10% P. gingivalis supernatant to the culture
medium optimally upregulated uPA secretion compared
to secretion in control cells. As determined by casein
zymography and Western blotting, treatment with 2-25 ì M
macelignan inhibited uPA secretion and protein expression
in P. gingivalis supernatant-treated KB cells in a dose-
dependent manner (Figure 3a). At the level of the gene,
10% P. gingivalis supernatant also induced the expression
of uPA mRNA in KB cells. The level of uPA mRNA was
effectively decreased after treatment with macelignan
(Figure 3a). We also investigated the effects of amiloride
and GM6001, inhibitors of uPA, and MMP, respectively.
The degree of suppression of uPA secretion by amiloride
(2-25 ìM) was equivalent to that of macelignan in P.
gingivalis supernatant-induced KB cells (Figure 3b). In
contrast, GM6001 had no effect on uPA secretion in P.
gingivalis supernatant-treated KB cells (Figure 3c).
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Figure 2. (a) Dose-dependent effect of P. gingivalis supernatant
on uPA secretion in KB cells assayed by casein
zymography. (b) Effect of P. gingivalis and macelignan
on KB cell viability. Values represent the mean + SD of
triplicate experiments. * indicates P < 0.05 against P.
gingivalis supernatant-treated cells.
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Macelignan Decreased MAPK Phosphorylation
Induced by P. gingivalis Supernatant. Inhibition of uPA
expression via MAPK signaling pathways in P. gingivalis
supernatant-treated KB cells was first determined by
casein zymography of conditioned medium from cells that
had been cultured in the presence of the specific MAPK
inhibitors U0126, SB203580, and SP600125 at a
concentration of 10 ìM. Figure 4a shows that the p38
inhibitor SB203580 and the JNK inhibitor SP600125
significantly reduced uPA secretion in P. gingivalis
supernatant-treated KB cells. We then carried out Western
analysis to determine whether macelignan interfered with
MAPK signaling pathway-mediated uPA expression in P.
gingivalis supernatant-induced KB cells (Figure 4b).
Exposure to P. gingivalis supernatant increased the
activation of MAPKs ERK1/2, p38 and JNK by
phosphorylation. Macelignan treatment decreased the
levels of phosphorylated p38 and JNK in P. gingivalis
supernatant-induced KB cells in a dose-dependent manner
comparable to that seen following treatment with the
specific MAPK inhibitors U0126, SB203580, and SP600125.
In contrast, macelignan exhibited a lesser inhibitory effect
on ERK1/2 phosphorylation than on phosphorylation of
p38 and JNK.
Macelignan Suppressed c-Jun Phosphorylation and
c-Fos Expression Induced by P. gingivalis Supernatant.
Because the JNK and p38 signaling pathways have been
associated with the transcription factors c-Jun and c-Fos,
the effect of P. gingivalis supernatant on c-Jun
phosphorylation and c-Fos expression in KB cells was
evaluated. Phosphorylation of c-Jun and expression of c-Fos
were upregulated by P. gingivalis supernatant treatment
in KB cells compared to control cells. Macelignan
treatment resulted in a partial reduction in c-Jun
phosphorylation and c-Fos expression in these cells
(Figure 4c).
Macelignan Blocked Transcription Factor AP-1
Activity Induced by P. gingivalis Supernatant. AP-1, a
transcription factor involved in uPA gene expression, is
composed of homo- and heterodimers of c-Jun and c-Fos.
The effect of P. gingivalis supernatant on activation of
AP-1 in KB cells was further tested using a luciferase
assay. Figure 5 shows that exposure of KB cells to P.
gingivalis supernatant increased AP-1 activation by
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Figure 3. (a) Effect of macelignan on the expression of uPA
secretion, protein, and mRNA in P. gingivalis
supernatant-induced KB cells assayed by casein
zymography, Western blotting and RT-PCR. (b-c)
Effects of amiloride and GM6001 on uPA secretion in
P. gingivalis supernatant-induced KB cells assayed by
casein zymography.
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Figure 4. (a) Effect of MAPK inhibitors on uPA secretion in P.
gingivalis supernatant-induced KB cells assayed by casein
zymography. (b) Effect of macelignan on P. gingivalis
supernatant-induced activation of MAPK signaling
pathways in KB cells assayed by Western blotting. (c)
Effect of macelignan on P. gingivalis supernatant-
induced activation of c-Jun phosphorylation and c-Fos
expression in KB cells assayed by Western blotting.
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approximately 3.2-fold over untreated cells. Macelignan
blocked AP-1 activity in a dose-dependent manner in
treated KB cells, and at the highest concentration (25 ìM),
the inhibitory activity of macelignan was greater than that
of the uPA inhibitor amiloride and the MMP inhibitor
GM6001.
DISCUSSION
Periodontal disease is marked by alternating periods
of extracellular matrix tissue breakdown and specifically
indicated by an increase in the expression of PAs, including
uPA. The uPA system also includes its endogenous
inhibitors, plasminogen activator inhibitor (PAI) types 1
and 2. Imbalance in the activities of uPA and PAIs has
been shown to contribute to the destruction of periodontal
connective tissue (Xiao et al. 2001). Smith and Martinez
(2006) reported the differential expression of uPA in healthy
and diseased human gingival tissues, suggesting that uPA
might play a key role in the process of periodontal
inflammation. Regulation of uPA expression is an important
strategy in prevention and treatment of periodontal
inflammation; however, the molecular mechanisms
controlling this process are not fully understood. An
important area of periodontal research involves the quest
for potent agents that will control inflammation with little
or no toxicity to normal cells and investigation of the
mechanisms by which these agents regulate uPA
expression.
We previously reported that macelignan exerts strong
antibacterial and antibiofilm activities that are effective
against periodontopathogens, suggesting the potential
use of macelignan as an antiplaque agent (Chung et al.
2006; Yanti et al. 2008) and in periodontal therapy. Here,
the inhibitory effect of macelignan on uPA expression and
its associated signaling pathways in P. gingivalis
supernatant-induced KB cells was clearly defined. Our
results showed that uPA production was upregulated by
exposure of KB cells to P. gingivalis supernatant
for 48 hours in culture (Figure 2a). P. gingivalis, a gram-
negative black-pigmented anaerobic bacterium, is
recognized as the main oral pathogen participating in dental
plaque accumulation. In periodontal disease, bacterial
products trigger the host cells to secrete inflammatory
mediators such as cytokines, prostaglandin and MMPs,
and lead to extracellular tissue breakdown (Schwartz et al.
1997). P. gingivalis culture supernatant contains virulence
factors such as gingipain, LPS and fimbriae, and induces
the expression of MMPs (MMP-1, MMP-2, and MMP-9)
and PAs (uPA and tPA) in various periodontal cell types
(Chang et al. 2002a,b, 2004, 2006; Yang et al. 2003; Smith
et al. 2004; Smith & Martinez 2006). Our results
demonstrated that P. gingivalis supernatant treatment
resulted in upregulation of uPA secretion, protein and
mRNA in KB cells; treatment with macelignan resulted in
a dose-dependent decrease in these parameters (Figure
3a). The effect of macelignan on uPA inhibition is very
similar to that of the uPA inhibitor amiloride (Figure 3b).
One group has reported that P. gingivalis LPS stimulates
uPA expression in human gingival fibroblasts (Ogura et
al. 1999); however, it is not known which components of
P. gingivalis supernatant share this activity with LPS and
how the effect is mediated in other periodontal cell types,
including KB cells.
The MAPK signaling pathways, ERK1/2, p38 and JNK,
have been associated with regulation of uPA gene
expression, although the profiles of MAPK activation
appear to vary in a cell type-dependent manner (Ward et
al. 2001; Adeyinka et al. 2002). Considering that MAPK
regulation of uPA expression may play a role in periodontal
inflammation, we investigated the ability of macelignan to
interrupt MAPK signaling pathways involved in uPA
expression in P. gingivalis supernatant-treated KB cells.
Casein zymographic analysis demonstrated that the p38
inhibitor SB203580 and the JNK inhibitor SP600125
significantly reduced uPA secretion induced by P.
gingivalis supernatant in KB cells (Figure 4a); this data
suggests that the p38 and JNK signaling pathways are
involved in uPA expression. Smith et al. (2004) reported
that inhibitors of ERK1/2 and JNK are involved in EGF-
induced uPA expression in human gingival fibroblasts.
Consistent with the results of casein zymography,
macelignan was found to reduce the levels of p38 and
JNK phosphorylation in KB cells exposed to P. gingivalis
supernatant (Figure 4b). This finding suggests that
macelignan downregulates P. gingivalis supernatant-
induced uPA gene expression by blocking the activation
of p38 and JNK phosphorylation in KB cells. Bioactive
compounds such as curcumin and genistein have been
reported to modulate MAPK signaling pathway-mediated
uPA expression in human gingival fibroblasts in response
to EGF (Smith et al. 2004). In addition, EGCG derived from
green tea also alters the production of uPA in human
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Figure 5. Effect of macelignan on AP-1 activity induced by P.
gingivalis supernatant in KB cells determined by
luciferase assay. Values represent the mean + SD of
triplicate experiments. # indicates P < 0.01 against
untreated cells. * and ** indicate P < 0.05 and P < 0.01
against P. gingivalis supernatant treated-cells.
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fibrosarcoma cells through ERK1/2 and JNK
phosphorylation (Kim et al. 2004). These studies show
that the higher levels of uPA expression were associated
with an imbalance in the levels of uPA and its endogenous
inhibitors (PAIs), causing extracellular matrix breakdown,
marked periodontal inflammation and cancer progression.
A major role of MAPKs is regulation of transcription factor
activity and transmission of extracellular signals to the
nucleus, where target gene expression is induced. The
JNK and p38 signaling pathways have been associated
with induction of transcription factors, including
phosphorylation of c-Jun and increasing the expression
level of c-Fos; these events lead to activation of the
AP-1 complex, the transcription factor responsible for
induction of uPA expression (Rao 2003). Because the JNK
and p38 signaling pathways involved in uPA expression
were significantly inhibited by macelignan, we
investigated the effect of macelignan on the
phosphorylation of c-Jun and expression of c-Fos induced
by P. gingivalis supernatant treatment of KB cells.
P. gingivalis supernatant upregulated MAPK activation,
followed by an increase in the phosphorylation of c-Jun
and expression of c-Fos, which comprise the AP-1 complex
(Figures 4b,c). These results imply that P. gingivalis
supernatant-induced uPA expression in KB cells is tightly
regulated at the transcriptional level and that MAPK
signaling pathways are critically involved in uPA
expression in these cells. These results are in agreement
with those of previous studies (Miralles et al. 1998; Parra
et al. 2000; Shin et al. 2003).
It has been clearly shown that macelignan decreased
the levels of c-Jun phosphorylation and c-Fos expression
(Figure 4c) and blocked AP-1 activity (Figure 5). Because
the AP-1 complex is comprised of c-Jun and c-Fos, the
significant effect of macelignan was linearly correlated
with a reduction in AP-1 activity. AP-1-regulated uPA
transcription is dependent not only on the proportion of
c-Jun and c-Fos in the complex, but also on the levels of
c-Jun phosphorylation and c-Fos expression (Waskiewicz
& Cooper 1995). Therefore, macelignan alters uPA gene
expression in P. gingivalis supernatant-induced KB cells
by partially decreasing c-Jun phosphorylation, c-Fos
expression and AP-1 activity. Several studies aimed at
investigating the molecular mechanisms underlying
regulation of uPA expression by natural agents in relation
to periodontal inflammation are currently underway.
However, simple comparisons are difficult to make due to
differences in the cellular sources of uPA, differences in
culture conditions, the nature of the compounds under
investigation and the concentrations used, and the
signaling pathways targeted by the agents. Although
studies using natural agents such as curcumin, genistein
and EGCG have been reported (Kim et al. 2004; Smith et
al. 2004), these studies focused primarily on the role of
signal transduction in uPA protein expression and not on
events at the transcriptional level.
In summary, our results strongly suggest that
macelignan suppresses expression of uPA induced by P.
gingivalis supernatant by blocking c-Jun phosphorylation,
c-Fos expression and AP-1 activity which may be
facilitated by the decreased levels of p38 and JNK
phosphorylation in KB cells. Macelignan may be
considered a potent candidate for use as a preventive
agent in the control of periodontal inflammation in oral
care functional foods.
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